Clinical trials: Familial Hypocalciuric Hypercalcemia
Multiple Endocrine Neoplasia
Studies of Inherited Diseases of Metabolism
Diseases of mineral metabolism such as familial multiple endocrine neoplasia type 1 (FMEN1), familial hypocaliuric hypercalcemia (FHH), familial hyperparathyroidism (FH), and pseudohypoparathyroidism (PHP) are known as hereditary…
- Trial name
- NCT00001345
- Where
- United States
- Volunteers
- 969 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Familial Hypocalciuric Hypercalcemia
Familial Hypocalciuric Hypercalcemia: Clinical Aspects and Evolution
Familial hypocalciuric hypercalcemia (FHH) is a rare disease (ORPHA#405, www.orpha.net) and most likely underdiagnosed, that clinicians should be aware of in the differential diagnosis of a hypercalcemia.
- Trial name
- NCT04872894
- Testing
- Observational study. No intervention is performed
- Where
- Spain
- Volunteers
- 70 people
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Diabetes, Cancer
Family Genetics Health Education and Healthy Behaviors
Background: Family-based approaches to reduce disease risk and promote healthy behaviors may be better than targeting individuals.
- Conditions
- Diabetes, Cancer, Heart Disease
- Trial name
- NCT01498276
- Where
- 2 sites in United States
- Volunteers
- 310 people
- Sponsor
- National Human Genome Research Institute (NHGRI)